Skip to content

Evaluation of the Safety and Effectiveness of the Kinamed Gem Ceramic Femoral Component for Total Knee Replacement

Clinical Trial on the Zirconia Femoral Component for the Gem Total Knee System

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00743717
Enrollment
4
Registered
2008-08-29
Start date
2004-02-29
Completion date
2012-12-31
Last updated
2013-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

total knee arthroplasty, osteoarthritis, ceramic bearing, zirconia

Brief summary

The aim of this study is to provide evidence that the safety and effectiveness of the ceramic femoral component of the Gem Total Knee System is similar to FDA approved implants used in total knee replacement surgery. The hypotheses to be tested are that the investigational and control groups are equivalent in terms of patient success rate and complication-free rate.

Detailed description

Due to excellent biocompatibility and wear characteristics, ceramics have a long history of success in total hip arthroplasty (THA). Use of a ceramic-polyethylene wear couple in total knee arthroplasty (TKA) has shown promising laboratory and early clinical results. The use of ceramics in this study is intended to address long-term failure of TKA due to osteolysis associated with polyethylene wear debris.

Interventions

DEVICEzirconia femoral component

total knee arthroplasty performed using implant with zirconia femoral component

DEVICEcobalt chrome femoral component

total knee arthroplasty performed using implant with cobalt chrome femoral component

Sponsors

Kinamed Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Skeletally mature * Primary TKA for osteoarthritis or post-traumatic arthritis of the knee joint * Stable or reconstructable collateral and posterior cruciate ligaments * Correctable deformity * Intact quadriceps and hamstrings mechanisms * Patella bone thick enough (at least 15 mm) after resection

Exclusion criteria

* Previous TKA * Bilateral knee arthritis * Non-availability for follow-up * Mental incompetence or confinement * Patients being treated with other investigational devices for same disorder * Infection * Osteoporosis, acute renal failure, or other disorders known to affect bone quality * Charcot's or Paget's disease * Patient physical condition preventing use of appropriate size implant * Disease conditions affecting blood supply to knee * Insufficient bone quality or quantity * Physical condition predisposing implant to extreme loads * History of septic knee arthritis * History of drug abuse

Design outcomes

Primary

MeasureTime frameDescription
Knee Score at 2 Years Post Operationwithin 2 yearsThe criterion used to assess the outcome is a Knee Score (as defined by Knee Society Clinical Rating System) \> 80 points at two-years follow-up. This scoring system is defined in the following paper: Insall JN, Dorr LD, Scott RD, and Scott WN (1989). Rationale of the Knee Society clinical rating system. Clin Orthop(248): 13-4. The scale ranges from minimum of 0 (worst) to maximum of 100 (best). Knee Score \> 80 was used as a criterion to assess success.

Participant flow

Recruitment details

Recruited during pre-op TKA clinical exam during year 2004.

Participants by arm

ArmCount
1: Zirconia Femoral
zirconia femoral component : total knee arthroplasty performed using implant with zirconia femoral component
2
2: CoCr Femoral
cobalt chrome femoral component : total knee arthroplasty performed using implant with cobalt chrome femoral component
2
Total4

Baseline characteristics

Characteristic2: CoCr Femoral1: Zirconia FemoralTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants1 Participants3 Participants
Age, Categorical
Between 18 and 65 years
0 Participants1 Participants1 Participants
Age Continuous65.5 years
STANDARD_DEVIATION 4.94
62.5 years
STANDARD_DEVIATION 13.4
64 years
STANDARD_DEVIATION 8.45
Region of Enrollment
United States
2 participants2 participants4 participants
Sex: Female, Male
Female
1 Participants2 Participants3 Participants
Sex: Female, Male
Male
1 Participants0 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 20 / 2
serious
Total, serious adverse events
0 / 20 / 2

Outcome results

Primary

Knee Score at 2 Years Post Operation

The criterion used to assess the outcome is a Knee Score (as defined by Knee Society Clinical Rating System) \> 80 points at two-years follow-up. This scoring system is defined in the following paper: Insall JN, Dorr LD, Scott RD, and Scott WN (1989). Rationale of the Knee Society clinical rating system. Clin Orthop(248): 13-4. The scale ranges from minimum of 0 (worst) to maximum of 100 (best). Knee Score \> 80 was used as a criterion to assess success.

Time frame: within 2 years

ArmMeasureValue (MEAN)
1: Zirconia FemoralKnee Score at 2 Years Post Operation91 units on a scale
2: CoCr FemoralKnee Score at 2 Years Post Operation89 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026